Non categorizzato FDA approves Biogen-Eisai Alzheimer drug Leqembi Luglio 6, 2023 0 commenti The United States Food and Drug Administration (FDA) announced on Thursday it granted traditional approval to the Alzheimer treatment Leqembi developed by Eisai Co. Ltd. and Biogen Inc. “Today&r… About the author:
Get involved!
Comments